Dr Lal PathLabs, Metropolis: Here's how healthcare stocks look on charts

Thyrocare Technologies has the strong support of 50-DMA, currently placed at Rs 988 levels.

Shares of diagnostic and healthcare services firms such as Metropolis Healthcare, Dr Lal PathLabs, and Thyrocare Technologies were trading in the positive territory on Tuesday, a day after the Maharashtra government imposed restrictions on all air and rail passengers arriving from Delhi, Gujarat, Rajasthan, and Goa. Passengers travelling from these states — which have seen a significant surge in cases — will have to obtain a negative RT-PCR test report before starting. READ MORE

Among individual stocks, Dr Dr Lal PathLabs rallied as much as 3.57 per cent to Rs 2,375.95 on the BSE while Metropolis Healthcare